This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Xiong, P. Articles by Wei, Q. Search for Related Content PubMed PubMed Citation Articles by Xiong, P. Articles by Wei, Q.

Sensitivity to Benzo(a)pyrene Diol-Epoxide Associated with Risk of Breast Cancer in Young Women and Modulation by Glutathione S-Transferase Polymorphisms

A Case-Control Study¹

Departments of Epidemiology [P. X., M. L. B., H. S., L-E. W., M. R. S., Q. W.], Gastrointestinal Medical Oncology [D. L.], and Surgical Oncology [S. E. S.], The University of Texas M. D. Anderson Cancer Center, Houston, Texas 77030

Mounting epidemiological evidence suggests that smoking may play a role in the etiology of breast cancer. Because smoking-related DNA adducts are detectable in both normal and malignant breast tissues, we hypothesized that breast cancer patients may be sensitive to tobacco-induced carcinogenesis, and this sensitivity could be modulated by variants of metabolic genes. To test this hypothesis, we evaluated benzo(a)pyrene diol-epoxide (BPDE)-induced mutagen sensitivity and polymorphisms of GSTM1 and GSTT1 in a pilot case-control study of breast cancer. Short-term cell cultures were established from blood samples of 100 female breast cancer patients and 105 healthy controls. After 5 h of in vitro exposure to 4 µM of BPDE, we harvested the lymphocytes for cytogenetic evaluation and recorded and compared the frequency of BPDE-induced chromatid breaks between cases and controls. We used a multiplex PCR-based assay to simultaneously detect polymorphisms of GSTM1 and GSTT1 from genomic DNA. We performed univariate and multivariate logistic regression analyses and calculated odds ratios (OR) and 95% confidence intervals (CIs). Cases had a significantly higher frequency of chromatid breaks than did controls (P < 0.0001). The level of chromatid breaks greater than the median value of controls was associated with a >3-fold increased risk of breast cancer [adjusted odds ratio (ORadj) = 3.11; 95% CI = 1.72–5.64]. The risk was more pronounced in those who were <45 years (ORadj = 4.79; 95% CI = 1.87–12.3), ever-smokers (ORadj = 5.55; 95% CI = 1.85–16.6), alcohol drinkers (ORadj = 4.64; 95% CI = 1.70–12.7), and those who had the GSTT1 null variant (ORadj = 8.01; 95% CI = 1.16–55.3). These data suggest that sensitivity to BPDE-induced chromosomal aberrations may contribute to the risk of developing breast cancer, and such sensitivity may be modulated by both genetic and environmental factors. Larger studies are needed to confirm our findings.

This article has been cited by other articles:

				K.-D. Yu, G.-H. Di, L. Fan, J. Wu, Z. Hu, Z.-Z. Shen, W. Huang, and Z.-M. Shao A functional polymorphism in the promoter region of GSTM1 implies a complex role for GSTM1 in breast cancer FASEB J, July 1, 2009; 23(7): 2274 - 2287. [Abstract] [Full Text] [PDF]

				J. Lu, Q. Wei, M. L. Bondy, D. Li, A. Brewster, S. Shete, T.-K. Yu, A. Sahin, F. Meric-Bernstam, K. K. Hunt, et al. Polymorphisms and haplotypes of the NBS1 gene are associated with risk of sporadic breast cancer in non-Hispanic white women <=55 years Carcinogenesis, November 1, 2006; 27(11): 2209 - 2216. [Abstract] [Full Text] [PDF]

				T. G. Natarajan, N. Ganesan, P. Carter-Nolan, C. A. Tucker, P. G. Shields, and L. L. Adams-Campbell {gamma}-Radiation-Induced Chromosomal Mutagen Sensitivity Is Associated with Breast Cancer Risk in African-American Women: Caffeine Modulates the Outcome of Mutagen Sensitivity Assay. Cancer Epidemiol. Biomarkers Prev., March 1, 2006; 15(3): 437 - 442. [Abstract] [Full Text] [PDF]

				L.-E Wang, P. Xiong, S. S. Strom, L. H. Goldberg, J. E. Lee, M. I. Ross, P. F. Mansfield, J. E. Gershenwald, V. G. Prieto, J. N. Cormier, et al. In Vitro Sensitivity to Ultraviolet B Light and Skin Cancer Risk: A Case-Control Analysis J Natl Cancer Inst, December 21, 2005; 97(24): 1822 - 1831. [Abstract] [Full Text] [PDF]

				D. O. Kennedy, M. Agrawal, J. Shen, M. B. Terry, F. F. Zhang, R. T. Senie, G. Motykiewicz, and R. M. Santella DNA Repair Capacity of Lymphoblastoid Cell Lines From Sisters Discordant for Breast Cancer J Natl Cancer Inst, January 19, 2005; 97(2): 127 - 132. [Abstract] [Full Text] [PDF]

				Q. Shi, L.-E. Wang, M. L. Bondy, A. Brewster, S. E. Singletary, and Q. Wei Reduced DNA repair of benzo[a]pyrene diol epoxide-induced adducts and common XPD polymorphisms in breast cancer patients Carcinogenesis, September 1, 2004; 25(9): 1695 - 1700. [Abstract] [Full Text] [PDF]

				K. M. Egan, Q. Cai, X.-O. Shu, F. Jin, T.-L. Zhu, Q. Dai, Y.-T. Gao, and W. Zheng Genetic Polymorphisms in GSTM1, GSTP1, and GSTT1 and the Risk for Breast Cancer: Results from the Shanghai Breast Cancer Study and Meta-Analysis Cancer Epidemiol. Biomarkers Prev., February 1, 2004; 13(2): 197 - 204. [Abstract] [Full Text] [PDF]

				D. Li, F. L. Walcott, P. Chang, W. Zhang, J. Zhu, E. Petrulis, S. E. Singletary, A. A. Sahin, and M. L. Bondy Genetic and Environmental Determinants on Tissue Response to in Vitro Carcinogen Exposure and Risk of Breast Cancer Cancer Res., August 15, 2002; 62(16): 4566 - 4570. [Abstract] [Full Text] [PDF]